Hints and tips:
...Impax Laboratories started selling mebendazole this year at an average wholesale price of $442 per pill, according to figures seen by the Financial Times, which were checked with several US pharmacy chains...
...Lannett Company, which has a market value of around $700m, dropped 19 per cent while Impax Laboratories (market cap $1.3bn) fell 12.4 per cent....
...The Federal Trade Commission accused it of paying $112m to Impax Laboratories in 2010 to delay for three years the introduction of a generic version of Opana ER, a controversial opioid-based painkiller that...
...Turing Pharmaceuticals bought the rights to Daraprim from Impax Laboratories in August for $55m — a huge amount for a drug that has been available since 1953 — and quickly raised the price to recoup its...
...Acura Pharmaceutical, the speciality pharmaceutical company said it had settled with both Par Pharmaceutical Companies and Impax Laboratories in a patent infringement case related to Acura’s pain drug Oxecta...
...Although there are two generics of Adderall XR on the market – produced under licence by Israel’s Teva Pharmaceuticals and Impax Laboratories of the US – the looming introduction of a new cut-price version...
...Merck jumped 1.5 per cent to $34.97 after it filed a patent-infringement lawsuit against Impax Laboratories which is seeking authorisation to sell a copy of Merck’s Vytorin....
...Earlier this year Shire settled a similar patent challenge with Impax Laboratories. Following this latest deal Impax will be allowed to market a generic 181 days after Barr launches its product....
...However, Adderral XR has already received a threat to its patents from Barr Laboratories, Impax Laboratories and Colony Pharmaceuticals, who have announced plans to apply to make a cheap version of the drug...
International Edition